Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons J.S. Hooiveld-Noeken

Publicaties

Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Towards less mutilating treatments in patients with advanced non-melanoma skin cancers by earlier use of immune checkpoint inhibitors

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

(89)ZED88082A PET imaging to visualize CD8(+) T cells in patients with cancer treated with immune checkpoint inhibitor.

First-in-human study of the biodistribution and pharmacokinetics of 89Zr-CX-072, a novel immunopet tracer based on an anti–PD-L1 probody

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy

Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response

Lees meer